for Alzheimer’s disease aducanumab CAS 1384260-65-4

designed to treat Alzheimer’s disease (AD).It is an amyloid beta-directed monoclonal antibody,that targets aggregated forms of amyloid beta (Aβ) found in the brains of people with Alzheimer’s disease to reduce its buildup